Skip to main content
Article
[Abstract] Protein profiling to identify serum biomarkers for early detection of breast cancer in African American women
Cancer Research (2006)
  • Padma P. Tadi-Uppala, Loma Linda University
  • William Blackledge
  • Larry Beeson, Loma Linda University
  • Pramila P. Thadi
  • Carlos A. Garberoglio, Loma Linda University
  • John Morgan
  • Gurunatha R. Uppala, Loma Linda University
  • Sharon S. Lum, Loma Linda University
  • Kumar VS Kolli
  • David Kirchner, Loma Linda University Medical Center
  • Alisha Preuss
  • Richard Mural, Loma Linda University Medical Center
  • Michael Liebman
  • Susanna Montgomery, Loma Linda University
Abstract
African American (AA) women have a higher lifetime risk of fatal breast cancer than White women. The age-standardized rate in AA women is approximately 30% higher than in White women. Important contributing factors suggested are hormonal, genetic, environmental and socioeconomic. The purpose of the study was to identify markers of early-stage breast cancer to prevent the disease among AA women. The original study includes 30 AA breast cancer women, 30 healthy controls, 20 DDT-exposed and 20 DDT -unexposed women. Hypothesis: We expect that changes taking place in the mammary gland prior to the appearance of breast cancer will be reflected in proteins that will appear in the blood. Methods: In this initial study, we utilized the 2-Dimensional Fluorescence Difference Gel Electrophoresis/ Mass Spectrometry (2D DIGE/MS) analyses of sera from three AA women newly diagnosed with breast cancer, two DDT-exposed AA women and four healthy women to identify breast cancer biomarkers. Images were processed using DeCyder software for differential in gel analysis (DIA). Proteins that were differentially expressed were picked for mass spectral analysis for protein identification. The spots were processed on Spot Handler Workstation (SHW) and the extracted peptides were subjected to MALDI MS and or LC/QTOF (Ettan MALDI Pro) analysis for protein identification. The data was processed with Masslynx 4.0 software to generate peak lists and processed MS/MS data was submitted for database searching through Mascot to identify the proteins. Results: A comparison of the serum proteomes derived from patients diagnosed with breast cancer and women exposed to DDT against healthy subjects yielded approximately eighty proteins whose expression was altered. These proteins were identified by MS. Conclusion: Our study indicates that the expression of several proteins was significantly altered in breast cancer and DDT-exposed women. Further studies are necessary to examine these biomarkers that were significantly different between breast cancer patients, DDT-exposed women and healthy subjects to examine their role in disease etiology. These proteins could serve as potential markers of early stage breast cancer to prevent the disease among African American women.
Publication Date
April 15, 2006
Publisher Statement
Proceeding of the American Association of Cancer Research 97th Annual Meeting 2006
Citation Information
Padma P. Tadi-Uppala, William Blackledge, Larry Beeson, Pramila P. Thadi, et al.. "[Abstract] Protein profiling to identify serum biomarkers for early detection of breast cancer in African American women" Cancer Research Vol. 66 Iss. 8 Supplement (2006) p. 671 - 672
Available at: http://works.bepress.com/padmaptadiuppala/40/